ID   NIBA1_HUMAN             Reviewed;         928 AA.
AC   Q9BZQ8; Q2TTR2; Q5TEM8; Q8TEI5; Q9H593; Q9H9Y8; Q9HCB9;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 146.
DE   RecName: Full=Protein Niban 1 {ECO:0000305};
DE   AltName: Full=Cell growth-inhibiting gene 39 protein;
DE   AltName: Full=Protein FAM129A;
GN   Name=NIBAN1 {ECO:0000312|HGNC:HGNC:16784};
GN   Synonyms=C1orf24, FAM129A, NIBAN; ORFNames=GIG39;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=11011112; DOI=10.1111/j.1349-7006.2000.tb01027.x;
RA   Majima S., Kajino K., Fukuda T., Otsuka F., Hino O.;
RT   "A novel gene 'Niban' upregulated in renal carcinogenesis: cloning by the
RT   cDNA-amplified fragment length polymorphism approach.";
RL   Jpn. J. Cancer Res. 91:869-874(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11318611; DOI=10.1006/geno.2001.6500;
RA   Sood R., Bonner T.I., Malakowska I., Stephan D.A., Robbins C.M.,
RA   Connors T.D., Morgenbesser S.D., Su K., Faruque M.U., Pinkett H.,
RA   Graham C., Baxevanis A.D., Klinger K.W., Landes G.M., Trent J.M.,
RA   Carpten J.D.;
RT   "Cloning and characterization of 13 novel transcripts and the human RGS8
RT   gene from the 1q25 region encompassing the hereditary prostate cancer
RT   (HPC1) locus.";
RL   Genomics 73:211-222(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a human cell growth inhibiting gene.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 522-928, AND VARIANT ASN-692.
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16949643; DOI=10.1016/j.humpath.2006.06.022;
RA   Matsumoto F., Fujii H., Abe M., Kajino K., Kobayashi T., Matsumoto T.,
RA   Ikeda K., Hino O.;
RT   "A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and
RT   Hashimoto's thyroiditis.";
RL   Hum. Pathol. 37:1592-1600(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-579; SER-596; SER-602;
RP   SER-646 AND SER-926, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-602 AND SER-926, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582; SER-602 AND SER-708, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J., Magee A.I.,
RA   Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
CC   -!- FUNCTION: Regulates phosphorylation of a number of proteins involved in
CC       translation regulation including EIF2A, EIF4EBP1 and RPS6KB1. May be
CC       involved in the endoplasmic reticulum stress response (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9BZQ8; P31749: AKT1; NbExp=2; IntAct=EBI-6916466, EBI-296087;
CC       Q9BZQ8; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-6916466, EBI-742054;
CC       Q9BZQ8; Q14192: FHL2; NbExp=6; IntAct=EBI-6916466, EBI-701903;
CC       Q9BZQ8; P06748: NPM1; NbExp=7; IntAct=EBI-6916466, EBI-78579;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16949643}. Membrane
CC       {ECO:0000305}; Lipid-anchor {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in various types of thyroid tumor such as
CC       papillary thyroid carcinomas and oxyphilic thyroid tumors but not in
CC       normal thyroid tissue (at protein level). Strongly expressed in heart,
CC       skeletal muscle, pancreas, white blood cells and prostate with moderate
CC       expression in colon and spleen. Expressed in renal carcinoma cells but
CC       not in normal kidney. {ECO:0000269|PubMed:11011112,
CC       ECO:0000269|PubMed:16949643}.
CC   -!- MISCELLANEOUS: 'Niban' means 'second' in Japanese.
CC   -!- SIMILARITY: Belongs to the Niban family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB17230.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB050477; BAB17230.1; ALT_INIT; mRNA.
DR   EMBL; AF288391; AAG60611.1; -; mRNA.
DR   EMBL; AK022527; BAB14079.1; -; mRNA.
DR   EMBL; AY550972; AAT52218.1; -; mRNA.
DR   EMBL; AL096819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL109865; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL109956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136086; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030531; AAH30531.1; -; mRNA.
DR   EMBL; AK074139; BAB84965.1; -; mRNA.
DR   CCDS; CCDS1364.1; -.
DR   RefSeq; NP_443198.1; NM_052966.3.
DR   SMR; Q9BZQ8; -.
DR   BioGRID; 125515; 8.
DR   IntAct; Q9BZQ8; 4.
DR   MINT; Q9BZQ8; -.
DR   STRING; 9606.ENSP00000356481; -.
DR   iPTMnet; Q9BZQ8; -.
DR   MetOSite; Q9BZQ8; -.
DR   PhosphoSitePlus; Q9BZQ8; -.
DR   BioMuta; FAM129A; -.
DR   DMDM; 22256936; -.
DR   CPTAC; CPTAC-1623; -.
DR   EPD; Q9BZQ8; -.
DR   jPOST; Q9BZQ8; -.
DR   MassIVE; Q9BZQ8; -.
DR   MaxQB; Q9BZQ8; -.
DR   PaxDb; Q9BZQ8; -.
DR   PeptideAtlas; Q9BZQ8; -.
DR   PRIDE; Q9BZQ8; -.
DR   ProteomicsDB; 79893; -.
DR   Antibodypedia; 34451; 194 antibodies.
DR   Ensembl; ENST00000367511; ENSP00000356481; ENSG00000135842.
DR   GeneID; 116496; -.
DR   KEGG; hsa:116496; -.
DR   UCSC; uc001gra.5; human.
DR   CTD; 116496; -.
DR   DisGeNET; 116496; -.
DR   GeneCards; NIBAN1; -.
DR   HGNC; HGNC:16784; NIBAN1.
DR   HPA; ENSG00000135842; Tissue enhanced (smooth muscle, urinary bladder).
DR   neXtProt; NX_Q9BZQ8; -.
DR   OpenTargets; ENSG00000135842; -.
DR   PharmGKB; PA162385951; -.
DR   VEuPathDB; HostDB:ENSG00000135842.16; -.
DR   eggNOG; ENOG502QVNR; Eukaryota.
DR   GeneTree; ENSGT00940000154149; -.
DR   HOGENOM; CLU_009718_0_1_1; -.
DR   InParanoid; Q9BZQ8; -.
DR   OMA; PKCRILP; -.
DR   OrthoDB; 164866at2759; -.
DR   PhylomeDB; Q9BZQ8; -.
DR   TreeFam; TF333351; -.
DR   PathwayCommons; Q9BZQ8; -.
DR   SIGNOR; Q9BZQ8; -.
DR   BioGRID-ORCS; 116496; 6 hits in 999 CRISPR screens.
DR   ChiTaRS; FAM129A; human.
DR   GeneWiki; FAM129A; -.
DR   GenomeRNAi; 116496; -.
DR   Pharos; Q9BZQ8; Tbio.
DR   PRO; PR:Q9BZQ8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9BZQ8; protein.
DR   Bgee; ENSG00000135842; Expressed in heart right ventricle and 237 other tissues.
DR   ExpressionAtlas; Q9BZQ8; baseline and differential.
DR   Genevisible; Q9BZQ8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   InterPro; IPR026088; Niban-like.
DR   PANTHER; PTHR14392; PTHR14392; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Lipoprotein; Membrane; Myristate; Phosphoprotein;
KW   Reference proteome; Stress response; Translation regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   CHAIN           2..928
FT                   /note="Protein Niban 1"
FT                   /id="PRO_0000213120"
FT   COMPBIAS        683..864
FT                   /note="Glu-rich"
FT   MOD_RES         579
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         596
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         602
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   MOD_RES         646
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         708
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         926
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   VARIANT         633
FT                   /note="S -> L (in dbSNP:rs12750174)"
FT                   /id="VAR_053533"
FT   VARIANT         692
FT                   /note="D -> N (in dbSNP:rs35704242)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_053534"
FT   VARIANT         720
FT                   /note="V -> M (in dbSNP:rs17313374)"
FT                   /id="VAR_053535"
FT   VARIANT         830
FT                   /note="G -> S (in dbSNP:rs35601690)"
FT                   /id="VAR_053536"
FT   CONFLICT        27
FT                   /note="N -> D (in Ref. 4; AAT52218)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="E -> G (in Ref. 3; BAB14079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="D -> E (in Ref. 3; BAB14079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        609
FT                   /note="L -> P (in Ref. 7; BAB84965)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        858
FT                   /note="V -> D (in Ref. 3; BAB14079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        863
FT                   /note="E -> D (in Ref. 3; BAB14079)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   928 AA;  103135 MW;  93717F41336488FE CRC64;
     MGGSASSQLD EGKCAYIRGK TEAAIKNFSP YYSRQYSVAF CNHVRTEVEQ QRDLTSQFLK
     TKPPLAPGTI LYEAELSQFS EDIKKWKERY VVVKNDYAVE SYENKEAYQR GAAPKCRILP
     AGGKVLTSED EYNLLSDRHF PDPLASSEKE NTQPFVVLPK EFPVYLWQPF FRHGYFCFHE
     AADQKRFSAL LSDCVRHLNH DYMKQMTFEA QAFLEAVQFF RQEKGHYGSW EMITGDEIQI
     LSNLVMEELL PTLQTDLLPK MKGKKNDRKR TWLGLLEEAY TLVQHQVSEG LSALKEECRA
     LTKGLEGTIR SDMDQIVNSK NYLIGKIKAM VAQPAEKSCL ESVQPFLASI LEELMGPVSS
     GFSEVRVLFE KEVNEVSQNF QTTKDSVQLK EHLDRLMNLP LHSVKMEPCY TKVNLLHERL
     QDLKSRFRFP HIDLVVQRTQ NYMQELMENA VFTFEQLLSP HLQGEASKTA VAIEKVKLRV
     LKQYDYDSST IRKKIFQEAL VQITLPTVQK ALASTCKPEL QKYEQFIFAD HTNMIHVENV
     YEEILHQILL DETLKVIKEA AILKKHNLFE DNMALPSESV SSLTDLKPPT GSNQASPARR
     ASAILPGVLG SETLSNEVFQ ESEEEKQPEV PSSLAKGESL SLPGPSPPPD GTEQVIISRV
     DDPVVNPVAT EDTAGLPGTC SSELEFGGTL EDEEPAQEEP EPITASGSLK ALRKLLTASV
     EVPVDSAPVM EEDTNGESHV PQENEEEEEK EPSQAAAIHP DNCEESEVSE REAQPPCPEA
     HGEELGGFPE VGSPASPPAS GGLTEEPLGP MEGELPGEAC TLTAHEGRGG KCTEEGDASQ
     QEGCTLGSDP ICLSESQVSE EQEEMGGQSS AAQATASVNA EEIKVARIHE CQWVVEDAPN
     PDVLLSHKDD VKEGEGGQES FPELPSEE
//
